{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:40:52Z","timestamp":1792006852827,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","award":["Dipartimenti di Eccellenza 2023-2027 (l. 232\/2016"],"award-info":[{"award-number":["Dipartimenti di Eccellenza 2023-2027 (l. 232\/2016"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","award":["art. 1"],"award-info":[{"award-number":["art. 1"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","award":["commi 314 - 337)."],"award-info":[{"award-number":["commi 314 - 337)."]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","award":["20228ZCHTE"],"award-info":[{"award-number":["20228ZCHTE"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002954","name":"Universit\u00e0 degli Studi di Milano - Bicocca","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002954","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-024-00638-0","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:02:49Z","timestamp":1715590969000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis"],"prefix":"10.1007","volume":"31","author":[{"given":"Paola","family":"Faverio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-6264","authenticated-orcid":false,"given":"Alessandro","family":"Maloberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rebora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Cristina Myriam","family":"Intravaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tognola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Toscani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Vitarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Spiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Giannattasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"638_CR1","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Meyers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"638_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.917973","volume":"28","author":"P Janowiak","year":"2022","unstructured":"Janowiak P, Szymanowska-Narloch A, Siemi\u0144ska A. IPF respiratory symptoms management-current evidence. Front Med (Lausanne). 2022;28(9): 917973.","journal-title":"Front Med (Lausanne)."},{"key":"638_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028\u201340.","journal-title":"Nat Med"},{"key":"638_CR4","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1073\/pnas.1621375114","volume":"114","author":"G Wernig","year":"2017","unstructured":"Wernig G, Chen SY, Cui L, Van Neste C, Tsai JM, Kambham N, Vogel H, Natkunam Y, Gilliland DG, Nolan G, Weissman IL. Unifying mechanism for different fibrotic diseases. Proc Natl Acad Sci USA. 2017;114:4757\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"638_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/archinte.164.5.551","volume":"164","author":"JR Kizer","year":"2004","unstructured":"Kizer JR, Zisman DA, Blumenthal NP, Kotloff RM, Kimmel SE, Strieter RM, et al. Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med. 2004;164(5):551\u20136.","journal-title":"Arch Intern Med"},{"issue":"7","key":"638_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.rmed.2010.02.008","volume":"104","author":"SD Nathan","year":"2010","unstructured":"Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med. 2010;104(7):1035\u201341.","journal-title":"Respir Med"},{"issue":"12","key":"638_CR7","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.3390\/ijms22126214","volume":"22","author":"T Parimon","year":"2021","unstructured":"Parimon T, Hohmann MS, Yao C. Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis. Int J Mol Sci. 2021;22(12):6214.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"638_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71(4):549\u201374.","journal-title":"Cell Mol Life Sci"},{"key":"638_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","volume":"173","author":"M Liu","year":"2021","unstructured":"Liu M, L\u00f3pez de Juan Abad B, Cheng K. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev. 2021;173:504\u201319.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"638_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.5830\/CVJA-2013-055","volume":"24","author":"L Maries","year":"2013","unstructured":"Maries L, Manitiu I. Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP). Cardiovasc J Afr. 2013;24(7):286\u20139.","journal-title":"Cardiovasc J Afr"},{"issue":"36","key":"638_CR11","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine SA, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"4","key":"638_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method Circulation. 1977;55(4):613\u20138.","journal-title":"Anatomic validation of the method. Circulation."},{"issue":"3","key":"638_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0735-1097(96)00552-9","volume":"29","author":"Y Liao","year":"1997","unstructured":"Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali JK. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol. 1997;29(3):641\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"638_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201370.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"638_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/eurheartj\/ehi017","volume":"26","author":"ML Bots","year":"2005","unstructured":"Bots ML, Westerink J, Rabelink TJ, de Koning EJ. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J. 2005;26(4):363\u20138.","journal-title":"Eur Heart J"},{"key":"638_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"2","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002;2:257\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"30","key":"638_CR17","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","volume":"40","author":"DHJ Thijssen","year":"2019","unstructured":"Thijssen DHJ, Bruno RM, van Mil ACCM, Holder SM, Faita F, Greyling A, Zock PL, Taddei S, Deanfield JE, Luscher T, Green DJ, Ghiadoni L. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40(30):2534\u201347.","journal-title":"Eur Heart J"},{"key":"638_CR18","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehq165","volume":"31","author":"The Reference Values for Arterial Stiffness\u2019 Collaboration","year":"2010","unstructured":"The Reference Values for Arterial Stiffness\u2019 Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: \u2018establishing normal and reference values.\u2019 Eur Heart J. 2010;31:2338\u201350.","journal-title":"Eur Heart J"},{"issue":"10","key":"638_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE Jr, Collard HR. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684\u201391.","journal-title":"Ann Intern Med"},{"issue":"2","key":"638_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1378\/chest.14-0453","volume":"147","author":"ES Kim","year":"2015","unstructured":"Kim ES, Choi SM, Lee J, Park YS, Lee CH, Yim JJ, Yoo CG, Kim YW, Han SK, Lee SM. Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis. Chest. 2015;147(2):430\u20137.","journal-title":"Chest"},{"key":"638_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107798","volume":"222","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Kropski JA, Jones MG, et al. Idiopathic pulmonary fibrosis: disease mechanisms and drug development. Pharmacol Ther. 2021;222: 107798.","journal-title":"Pharmacol Ther"},{"key":"638_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/jcm6010002","volume":"6","author":"A Betensley","year":"2017","unstructured":"Betensley A, Sharif R, Karamichos D. A systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis. J Clin Med. 2017;6:2.","journal-title":"J Clin Med"},{"issue":"17","key":"638_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"24","author":"BJ Moss","year":"2022","unstructured":"Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol. 2022;24(17):515\u201346.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"638_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11739-020-02376-2","volume":"16","author":"E Cocconcelli","year":"2021","unstructured":"Cocconcelli E, Tonelli R, Abbati G, Marchioni A, Castaniere I, Pelizzaro F, Russo FP, Vegetti A, Balestro E, Pietrangelo A, Richeldi L, Luppi F, Spagnolo P, Clini E, Cerri S. Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis. Intern Emerg Med. 2021;16(2):349\u201357.","journal-title":"Intern Emerg Med"},{"key":"638_CR25","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s10554-020-01887-5","volume":"36","author":"A Sonaglioni","year":"2020","unstructured":"Sonaglioni A, Caminati A, Lipsi R, Nicolosi GL, Lombardo M, Anz\u00e0 C, Harari S. Early left atrial dysfunction in idiopathic pulmonary fibrosis patients without chronic right heart failure. Int J Cardiovasc Imaging. 2020;36:1711\u201323.","journal-title":"Int J Cardiovasc Imaging"},{"key":"638_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1183\/09031936.00102107","volume":"31","author":"CE Papadopoulos","year":"2008","unstructured":"Papadopoulos CE, Pitsiou G, Karamitsos TD, Karvounis HI, Kontakiotis T, Giannakoulas G, Efthimiadis GK, Argyropoulou P, Parharidis GE, Bouros D. Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study. Eur Respir J. 2008;31:701\u20136.","journal-title":"Eur Respir J"},{"key":"638_CR27","doi-asserted-by":"publisher","unstructured":"Sonaglioni A, Caminati A, Nicolosi GL, Lombardo M, Harari S. Incremental prognostic value of arterial elastance in mild-to-moderate idiopathic pulmonary fibrosis. Int J Cardiovasc Imaging. 2022. https:\/\/doi.org\/10.1007\/s10554-022-02541-y.","DOI":"10.1007\/s10554-022-02541-y"},{"issue":"2","key":"638_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.chest.2018.11.015","volume":"155","author":"A D'Andrea","year":"2019","unstructured":"D\u2019Andrea A, Stanziola AA, Saggar R, Saggar R, Sperlongano S, Conte M, D\u2019Alto M, Ferrara F, Gargani L, Lancellotti P, Bossone E, RIGHT Heart International NETwork (RIGHT-NET) Investigators. Right ventricular functional reserve in early-stage idiopathic pulmonary fibrosis: an exercise two-dimensional speckle tracking doppler echocardiography study. Chest. 2019;155(2):297\u2013306.","journal-title":"Chest"},{"issue":"12","key":"638_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1291\/hypres.28.937","volume":"28","author":"T Nakamura","year":"2005","unstructured":"Nakamura T, Fujii S, Hoshino J, Saito Y, Mizuno H, Saito Y, Kurabayashi M. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients. Hypertens Res. 2005;28(12):937\u201343.","journal-title":"Hypertens Res"},{"issue":"4","key":"638_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1161\/hy1001.095774","volume":"38","author":"RG Asmar","year":"2001","unstructured":"Asmar RG, London GM, O\u2019Rourke ME, Safar ME, REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril\/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension. 2001;38(4):922\u20136.","journal-title":"Hypertension"},{"key":"638_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-023-07529-x","author":"IVG Schettini","year":"2023","unstructured":"Schettini IVG, Barreto SM, Brant LCC, Ribeiro ALP, Mill JG, Rios DRA, Figueiredo RC. Use of antihypertensive drugs and arterial stiffness in the longitudinal study of adult health (ELSA-Brasil). Cardiovasc Drugs Ther. 2023. https:\/\/doi.org\/10.1007\/s10557-023-07529-x.","journal-title":"Cardiovasc Drugs Ther"},{"key":"638_CR32","doi-asserted-by":"publisher","unstructured":"Pali\u0107 B, Brizi\u0107 I, Sher EK, Cvetkovi\u0107 I, D\u017eidi\u0107-Krivi\u0107 A, Abdelghani HTM, Sher F. Effects of zofenopril on arterial stiffness in hypertension patients. Mol Biotechnol. 2023. https:\/\/doi.org\/10.1007\/s12033-023-00861-5.","DOI":"10.1007\/s12033-023-00861-5"},{"issue":"1","key":"638_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/08037051.2017.1378069","volume":"27","author":"P Meani","year":"2018","unstructured":"Meani P, Maloberti A, Sormani P, Colombo G, Giupponi L, Stucchi M, Varrenti M, Vallerio P, Facchetti R, Grassi G, Mancia G, Giannattasio C. Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up. Blood Press. 2018;27(1):32\u201340.","journal-title":"Blood Press"},{"issue":"2","key":"638_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/1573402113666170724100418","volume":"14","author":"I Tan","year":"2018","unstructured":"Tan I, Butlin M, Spronck B, Xiao H, Avolio A. Effect of heart rate on arterial stiffness as assessed by pulse wave velocity. Curr Hypertens Rev. 2018;14(2):107\u201322.","journal-title":"Curr Hypertens Rev"},{"issue":"5","key":"638_CR35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2019.06.030","volume":"13","author":"TD Karamitsos","year":"2020","unstructured":"Karamitsos TD, Arvanitaki A, Karvounis H, Neubauer S, Ferreira VM. Myocardial tissue characterization and fibrosis by imaging. JACC Cardiovasc Imaging. 2020;13(5):1221\u201334.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"638_CR36","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10741-022-10214-0","volume":"27","author":"M Lisi","year":"2022","unstructured":"Lisi M, Cameli M, Mandoli GE, Pastore MC, Righini FM, D\u2019Ascenzi F, Focardi M, Rubboli A, Mondillo S, Henein MY. Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications. Heart Fail Rev. 2022;27(5):1857\u201367.","journal-title":"Heart Fail Rev"},{"key":"638_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105924","volume":"174","author":"D Gupta","year":"2021","unstructured":"Gupta D, Kumar A, Mandloi A, Shenoy V. Renin angiotensin aldosterone system in pulmonary fibrosis: pathogenesis to therapeutic possibilities. Pharmacol Res. 2021;174: 105924.","journal-title":"Pharmacol Res"},{"issue":"1","key":"638_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10741-018-9720-1","volume":"24","author":"E Tarbit","year":"2019","unstructured":"Tarbit E, Singh I, Peart JN, Rose\u2019Meyer RB. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells. Heart Fail Rev. 2019;24(1):1\u201315.","journal-title":"Heart Fail Rev"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-024-00638-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-024-00638-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-024-00638-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T02:07:36Z","timestamp":1717812456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-024-00638-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["638"],"URL":"https:\/\/doi.org\/10.1007\/s40292-024-00638-0","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"23 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported and funded by a grant from the Italian Ministry of Universities and Research (MIUR): grant number 20228ZCHTE (\u201cPRIN: Progetto di Ricerca di Interesse Nazionale\u201d, \u201cCardiovascular Fibrotic involvement in Idiopathic Pulmonary Fibrosis: imaging and functional characterization, and biomolecular pathway analysis\u201d). Italian Ministry of Universities and Research had no role in the design of the study, the collection, analysis, and interpretation of the data, as well as the writing of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors have no conflict of interest to declare","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}